Authors
Balasegaram, MKolb, P
McKew, J
Menon, J
Olliaro, P
Sablinski, T
Thomas, Z
Todd, MH
Torreele, E
Wilbanks, J
Issue Date
2017-04-18Submitted date
2017-04-24
Metadata
Show full item recordJournal
PLoS MedicineAbstract
In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.Publisher
Public Library of SciencePubMed ID
28419094Language
enISSN
1549-1676ae974a485f413a2113503eed53cd6c53
10.1371/journal.pmed.1002276
Scopus Count
Collections
Related articles
- Competition: Unlikely partnerships.
- Authors: Savage N
- Issue date: 2016 May 12
- Q&A: Bernard Munos.
- Authors: Bender E
- Issue date: 2016 May 12
- China spurs pharma innovation.
- Authors: Hughes B
- Issue date: 2010 Aug
- How should we support pharmaceutical innovation?
- Authors: Grootendorst P
- Issue date: 2009 Aug
- Busting the billion-dollar myth: how to slash the cost of drug development.
- Authors: Maxmen A
- Issue date: 2016 Aug 25